A Comparative Analysis of Phyto-components on EGFR Binding, Viability, and Migration in HPV Positive ME180 and HPV Negative C33A Cervical Cancer Cells

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2023 Nov 14

PMID 37964051

Authors

Rajalakshmi Sabanayagam

Sneha Krishnamoorthy

Mohan Anbuselvam

Bharathi Muruganantham

Sridhar Muthusami

Affiliations

Soon will be listed here.

Abstract

A need for effective implementation of cervical cancer (CC) even in developed countries insist the urge for developing an effective drug molecule to treat CC. Previously, we showed an inverse correlation between survival of CC patients and epidermal growth factor (EGF) receptor (EGFR) levels. Newer tyrosine kinase inhibitors to treat CC are being constantly pursued. In this context, the proposed study is an attempt to perform a comparative analysis using 20 phyto-components to determine the effective lead molecule. Molecular docking was utilized to determine the comparative efficacy of 20 phyto-components in binding to EGFR. It was then validated by cell viability, mitochondrial membrane potential, apoptosis, migration, and matrix metalloproteinase (MMP-2) in human papilloma virus (HPV) positive and HPV negative CC cells using top nine phyto-components based on computational screening. Computational analysis identified nine phyto-components out of which five compounds were effective in reducing the survival, mitochondrial membrane potential, apoptosis, migration, and MMP-2 secretion. EGCG, plumbagin, quercetin, emodin, and naringenin were identified as effective molecules in attenuating CC survival, proliferation, and migration.

Citing Articles

Potential JAK2 Inhibitors from Selected Natural Compounds: A Promising Approach for Complementary Therapy in Cancer Patients.

Vaziri-Amjad S, Rahgosha R, Taherkhani A Evid Based Complement Alternat Med. 2024; 2024:1114928.

PMID: 38706884 PMC: 11068457. DOI: 10.1155/2024/1114928.

Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.

Krishnamoorthy S, Sabanayagam R, Periyasamy L, Muruganantham B, Muthusami S Med Oncol. 2024; 41(4):89.

PMID: 38520625 DOI: 10.1007/s12032-024-02332-6.

References

Muthusami S, Sabanayagam R, Periyasamy L, Muruganantham B, Park W . A review on the role of epidermal growth factor signaling in the development, progression and treatment of cervical cancer. Int J Biol Macromol. 2021; 194:179-187. DOI: 10.1016/j.ijbiomac.2021.11.117. View

Mohan A, Krishnamoorthy S, Sabanayagam R, Schwenk G, Feng E, Ji H . Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer. Eur J Pharmacol. 2023; 957:175961. DOI: 10.1016/j.ejphar.2023.175961. View

Muthusami S, Prabakaran D, An Z, Yu J, Park W . EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells. Mol Biol Rep. 2013; 40(10):5587-96. DOI: 10.1007/s11033-013-2660-x. View

Aarthy M, Panwar U, Singh S . Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7. Sci Rep. 2020; 10(1):8661. PMC: 7250877. DOI: 10.1038/s41598-020-65446-7. View

Khan M, Hussain A, Sundaram M, AlAlami U, Gunasekera D, Ramesh L . (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncol Rep. 2015; 33(4):1976-84. DOI: 10.3892/or.2015.3802. View

Pal D, Sur S, Roy R, Mandal S, Panda C . Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line. J Cell Physiol. 2018; 234(1):825-836. DOI: 10.1002/jcp.26900. View

McDonnell A, Pyles H, Diaz-Cruz E, Barton C . Enoxacin and Epigallocatechin Gallate (EGCG) Act Synergistically to Inhibit the Growth of Cervical Cancer Cells in Culture. Molecules. 2019; 24(8). PMC: 6514544. DOI: 10.3390/molecules24081580. View

Motallebi M, Bhia M, Rajani H, Bhia I, Tabarraei H, Mohammadkhani N . Naringenin: A potential flavonoid phytochemical for cancer therapy. Life Sci. 2022; 305:120752. DOI: 10.1016/j.lfs.2022.120752. View

Kim J, Kang J, Kim M, Bak Y, Park Y, Jung K . The apoptotic effects of the flavonoid N101-2 in human cervical cancer cells. Toxicol In Vitro. 2011; 26(1):67-73. DOI: 10.1016/j.tiv.2011.10.012. View

10.

Ma C, Gu Y, Liu C, Tang X, Yu J, Li D . Anti-cervical cancer effects of Compound Yangshe granule through the PI3K/AKT pathway based on network pharmacology. J Ethnopharmacol. 2022; 301:115820. DOI: 10.1016/j.jep.2022.115820. View

11.

Sundaram M, Raina R, Afroze N, Bajbouj K, Hamad M, Haque S . Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells. Biosci Rep. 2019; 39(8). PMC: 6692570. DOI: 10.1042/BSR20190720. View

12.

Chen X, Xu P, Zhang H, Su X, Guo L, Zhou X . EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells . Oncol Lett. 2021; 22(5):754. PMC: 8436358. DOI: 10.3892/ol.2021.13015. View

13.

Bhat F, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S . Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem. 2014; 25(11):1132-1139. DOI: 10.1016/j.jnutbio.2014.06.008. View

14.

Yaoxian W, Hui Y, Yunyan Z, Yanqin L, Xin G, Xiaoke W . Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway. Cancer Cell Int. 2013; 13(1):71. PMC: 3722080. DOI: 10.1186/1475-2867-13-71. View

15.

Srinivas G, Anto R, Srinivas P, Vidhyalakshmi S, Senan V, Karunagaran D . Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9. Eur J Pharmacol. 2003; 473(2-3):117-25. DOI: 10.1016/s0014-2999(03)01976-9. View

16.

Wang Y, Yu H, Zhang J, Ge X, Gao J, Zhang Y . Anti-tumor effect of emodin on gynecological cancer cells. Cell Oncol (Dordr). 2015; 38(5):353-63. DOI: 10.1007/s13402-015-0234-8. View

17.

Thacker P, Karunagaran D . Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. PLoS One. 2015; 10(3):e0120045. PMC: 4365016. DOI: 10.1371/journal.pone.0120045. View

18.

Roy A . Plumbagin: A Potential Anti-cancer Compound. Mini Rev Med Chem. 2020; 21(6):731-737. DOI: 10.2174/1389557520666201116144421. View

19.

Jaiswal A, Sabarwal A, Narayan Mishra J, Singh R . Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells. RSC Adv. 2022; 8(56):32022-32037. PMC: 9085811. DOI: 10.1039/c8ra05339a. View

20.

Nair S, Nair R, Srinivas P, Srinivas G, Pillai M . Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway. Mol Carcinog. 2007; 47(1):22-33. DOI: 10.1002/mc.20359. View